Zylox-Tonbridge and Avinger Collaborate on OCT Solutions for Peripheral Vascular Interventions

Zylox-Tonbridge, based in Hangzhou, China, has entered into a collaboration with Avinger to localise, manufacture and commercialise the full product portfolios of Avinger in Greater China (including Mainland China, Hong Kong, Taiwan and Macau), as well as a technology transfer agreement to leverage Zylox-Tonbridge’s low-cost manufacturing capabilities to support Avinger’s global sales outside of Greater China.

The collaboration also provides Avinger with the opportunity to distribute Zylox-Tonbridge’s high quality peripheral vascular products in the US and Germany. Based on the achievement of certain milestones, Zylox-Tonbridge will invest $15 million in Avinger in two tranches by subscribing for newly issued common and preferred shares of Avinger.

Avinger is globally recognized for its pioneering OCT-guided, catheter-based system and devices that provide real-time intra-vascular imaging during treatment. This innovation empowers physicians to precisely identify and treat diseased vessels while minimizing vascular damage risks. Avinger’s flagship products include Pantheris (an OCT-guided atherectomy device), Ocelot and Tigereye (OCT-guided CTO-crossing devices), and LightBox 3 (the OCT imaging console). These products have demonstrated clinical safety and efficacy in multiple clinical trials completed by Avinger.

We believe this collaboration will expand our Peripheral Vascular Intervention product portfolio, reinforcing our market leadership, and accelerating the growth of the vessel preparation business in China. Leveraging our advanced manufacturing capabilities and working with Avinger, we are confident in bringing more cost-efficient and high-quality products to patients. We are looking forward to cooperating with global partners to capitalize on growing market opportunities by offering high-quality and affordable innovative medical products and services for all,” said Dr. Jonathon Zhao, Chairman and CEO of Zylox-Tonbridge.

The partnership creates an exciting new pathway for Avinger products to enter the large and growing Greater China market through an established commercial channel. It also provides the opportunity for a more cost-efficient manufacturing structure to support the growth of global sales, as well as the potential for Avinger to access Zylox-Tonbridge’s high-quality peripheral products for distribution in the U.S. and Germany,” said Jeffrey M. Soinski, President and CEO of Avinger.

en_GBEnglish (UK)